SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kobo Biotech informs about newspaper publication

20 Sep 2022 Evaluate

With reference to the Notice dated 30th May, 2022 convening 29th Annual General Meeting (AGM) of the Company to be held on Friday, the 30th day of September, 2022 at 10.00 am (IST), through Video Conferencing / Other Audio-Visual Means (‘VC/OAVM’). Kobo Biotech has submitted newspaper publication of corrigendum which was issued with respect to Item No.3 of the Notice and the Explanatory Statement. This is in compliance with the provision of above-mentioned regulations and for the information.

The above information is a part of company’s filings submitted to BSE.

Kobo Biotech Share Price

2.74 0.12 (4.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×